The Board of Directors of Shree Ganesh Remedies Limited at its meeting held on October 31, 2026, approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026. The meeting commenced at 04:30 p.m. and concluded at 05:00 p.m. The results were prepared pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Financial Performance Highlights (Standalone)

Quarter Ended September 30, 2026:

  • Revenue from Operations: ₹2,329.47 lakhs (compared to ₹3,031.50 lakhs in Q2 FY25)
  • Other Income: ₹140.60 lakhs (compared to ₹68.98 lakhs in Q2 FY25)
  • Total Income: ₹2,470.07 lakhs (compared to ₹3,100.49 lakhs in Q2 FY25)
  • Profit Before Tax: ₹226.35 lakhs (compared to ₹671.11 lakhs in Q2 FY25)
  • Profit After Tax: ₹163.46 lakhs (compared to ₹495.57 lakhs in Q2 FY25)
  • Basic EPS: ₹1.28 (compared to ₹3.86 in Q2 FY25)

Half Year Ended September 30, 2026:

  • Revenue from Operations: ₹3,765.47 lakhs (compared to ₹5,498.29 lakhs in H1 FY25)
  • Other Income: ₹234.52 lakhs (compared to ₹135.16 lakhs in H1 FY25)
  • Total Income: ₹3,999.99 lakhs (compared to ₹5,633.44 lakhs in H1 FY25)
  • Profit Before Tax: ₹379.47 lakhs (compared to ₹1,130.91 lakhs in H1 FY25)
  • Profit After Tax: ₹275.47 lakhs (compared to ₹840.51 lakhs in H1 FY25)
  • Basic EPS: ₹2.15 (compared to ₹6.55 in H1 FY25)

Balance Sheet Position (Standalone as at September 30, 2026)

Assets:

  • Total Assets: ₹21,037.48 lakhs (compared to ₹20,773.62 lakhs as at March 31, 2026)
  • Non-current Assets: ₹12,285.42 lakhs (including Property, Plant and Equipment: ₹6,462.99 lakhs, Capital Work-in-progress: ₹1,630.06 lakhs)
  • Current Assets: ₹8,752.06 lakhs (including Inventories: ₹3,352.92 lakhs, Trade Receivables: ₹2,112.13 lakhs, Cash and Cash Equivalents: ₹1,727.74 lakhs)

Equity and Liabilities:

  • Total Equity: ₹16,579.48 lakhs (Equity Share Capital: ₹1,283.76 lakhs, Other Equity: ₹15,295.72 lakhs)
  • Total Liabilities: ₹4,458.00 lakhs
  • Non-current Liabilities: ₹2,260.53 lakhs (including Borrowings: ₹2,062.09 lakhs)
  • Current Liabilities: ₹2,197.47 lakhs (including Borrowings: ₹536.90 lakhs, Trade Payables: ₹1,484.04 lakhs)

Cash Flow Statement (Standalone H1 FY26)

  • Net Cash from Operating Activities: ₹1,463.71 lakhs
  • Net Cash used in Investing Activities: ₹(516.31) lakhs
  • Net Cash used in Financing Activities: ₹(555.06) lakhs
  • Net decrease in cash and cash equivalents: ₹(555.06) lakhs
  • Cash and cash equivalents at end of period: ₹1,727.74 lakhs

Additional Information

The financial results have been reviewed by Chaudhary Shah and Associates LLP, Chartered Accountants (FRN:006212C/W100789). The company is engaged in manufacturing of API Intermediates & Speciality Chemicals. The notes indicate that the financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) and that EPS calculations are based on weighted average number of shares outstanding during the period.